Sort
17,828 grants matching “crispr”
Integrating Omics, Networks, and Functional Studies in COPD and IPF
$485,987Edwin K Silverman · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · HL
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
$485,968Keiran Smalley · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · CA
HIV restriction by APOBEC3A
$485,931Viviana A Simon · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · AI
Mechanisms of Variant ER-alpha Function in Breast Cancer
$485,788Elaine T Alarid · University Of Wisconsin-Madison · R01 · FY2021 · CA
Decoding the Interferome by Mapping Genetic Interactions in Human Tissue
$485,725Ryan Gilbert Gaudet · Columbia University Health Sciences · DP2 · FY2024 · AI
Decoding the Interferome by Mapping Genetic Interactions in Human Tissue
$485,725Ryan Gilbert Gaudet · Columbia University Health Sciences · DP2 · FY2025 · AI
Mechanism and therapeutic opportunities of targeting the Tudor domain
$485,717Chun-Wei David Chen · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Functional dissection of fibronectin type 3 domains of SORL1 in Alzheimers disease associated microglia
$485,688Falak Sher · Columbia University Health Sciences · R01 · FY2022 · AG
Aneuploidy and Acquired Antifungal Drug Resistance in Candida species
$485,674Anna M. Selmecki · University Of Minnesota · R01 · FY2025 · AI
Project 2: Functional Genetic Networks for Systems-Guided Precision Medicine
$485,626Stephanie Irene Fraley · University Of California, San Francisco · U54 · FY2024 · CA
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
$485,407Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
$485,407Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Normal ABL1 kinase as tumor suppressor and therapeutic target in leukemia
$485,369Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2017 · CA
Normal ABL1 kinase as tumor suppressor and therapeutic target in leukemia
$485,369Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2018 · CA
Epigenetics of inner ear neurosensory cell development
$485,324Donna M Martin · University Of Michigan At Ann Arbor · R01 · FY2022 · DC
Role of cellular long non-coding RNAs in HIV replication and disease outcome
$485,200Smita Kulkarni · Texas Biomedical Research Institute · R01 · FY2022 · AI
Sulfide metabolism and signaling
$485,057Ruma V Banerjee · University Of Michigan At Ann Arbor · R35 · FY2025 · GM
Eukaryotic transcriptome engineering via sequence-specific regulation of endogenous RNA
$485,000Patrick Hsu · Salk Institute For Biological Studies · DP5 · FY2017 · OD
Eukaryotic transcriptome engineering via sequence-specific regulation of endogenous RNA
$485,000Patrick Hsu · Salk Institute For Biological Studies · DP5 · FY2016 · OD
Eukaryotic transcriptome engineering via sequence-specific regulation of endogenous RNA
$485,000Patrick Hsu · Salk Institute For Biological Studies · DP5 · FY2015 · OD
Directing Function at the Natural Killer Cell Secretory Immunological Synapse
$484,883Jordan Scott Orange · Columbia University Health Sciences · R37 · FY2025 · AI
The function of LIN28B and follistatin in supporting cell reprogramming and hair cell regeneration in the murine cochlea
$484,777Angelika Doetzlhofer · Johns Hopkins University · R01 · FY2024 · DC
The function of LIN28B and follistatin in supporting cell reprogramming and hair cell regeneration in the murine cochlea
$484,777Angelika Doetzlhofer · Johns Hopkins University · R01 · FY2023 · DC
The function of LIN28B and follistatin in supporting cell reprogramming and hair cell regeneration in the murine cochlea
$484,777Angelika Doetzlhofer · Johns Hopkins University · R01 · FY2025 · DC
Mechanisms of Variant ER-alpha Function in Breast Cancer
$484,754Elaine T Alarid · University Of Wisconsin-Madison · R01 · FY2023 · CA